The effect of Liraglutide treatment on postprandial chylomicron and VLDL kinetics, liver fat and de novo lipogenesis. A single-center randomized controlled study.

Trial Profile

The effect of Liraglutide treatment on postprandial chylomicron and VLDL kinetics, liver fat and de novo lipogenesis. A single-center randomized controlled study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms LIRA
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
    • 15 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top